295 related articles for article (PubMed ID: 28486709)
1. Anhedonia: Its Dynamic Relations With Craving, Negative Affect, and Treatment During a Quit Smoking Attempt.
Cook JW; Lanza ST; Chu W; Baker TB; Piper ME
Nicotine Tob Res; 2017 Jun; 19(6):703-709. PubMed ID: 28486709
[TBL] [Abstract][Full Text] [Related]
2. What a difference a day makes: differences in initial abstinence response during a smoking cessation attempt.
Piper ME; Vasilenko SA; Cook JW; Lanza ST
Addiction; 2017 Feb; 112(2):330-339. PubMed ID: 27633341
[TBL] [Abstract][Full Text] [Related]
3. Effect of nicotine lozenges on affective smoking withdrawal symptoms: secondary analysis of a randomized, double-blind, placebo-controlled clinical trial.
Shiffman S
Clin Ther; 2008 Aug; 30(8):1461-75. PubMed ID: 18803988
[TBL] [Abstract][Full Text] [Related]
4. Why two smoking cessation agents work better than one: role of craving suppression.
Bolt DM; Piper ME; Theobald WE; Baker TB
J Consult Clin Psychol; 2012 Feb; 80(1):54-65. PubMed ID: 22103958
[TBL] [Abstract][Full Text] [Related]
5. Anxiety Sensitivity and Distress Tolerance in Smokers: Relations With Tobacco Dependence, Withdrawal, and Quitting Success†.
Schlam TR; Baker TB; Smith SS; Cook JW; Piper ME
Nicotine Tob Res; 2020 Jan; 22(1):58-65. PubMed ID: 31056710
[TBL] [Abstract][Full Text] [Related]
6. Time-varying effects of 'optimized smoking treatment' on craving, negative affect and anhedonia.
Kim N; McCarthy DE; Cook JW; Piper ME; Schlam TR; Baker TB
Addiction; 2021 Mar; 116(3):608-617. PubMed ID: 32830368
[TBL] [Abstract][Full Text] [Related]
7. Evaluating the temporal relationships between withdrawal symptoms and smoking relapse.
Robinson JD; Li L; Chen M; Lerman C; Tyndale RF; Schnoll RA; Hawk LW; George TP; Benowitz NL; Cinciripini PM
Psychol Addict Behav; 2019 Mar; 33(2):105-116. PubMed ID: 30614717
[TBL] [Abstract][Full Text] [Related]
8. Evaluating the effect of smoking cessation treatment on a complex dynamical system.
Bekiroglu K; Russell MA; Lagoa CM; Lanza ST; Piper ME
Drug Alcohol Depend; 2017 Nov; 180():215-222. PubMed ID: 28922651
[TBL] [Abstract][Full Text] [Related]
9. Tobacco withdrawal components and their relations with cessation success.
Piper ME; Schlam TR; Cook JW; Sheffer MA; Smith SS; Loh WY; Bolt DM; Kim SY; Kaye JT; Hefner KR; Baker TB
Psychopharmacology (Berl); 2011 Aug; 216(4):569-78. PubMed ID: 21416234
[TBL] [Abstract][Full Text] [Related]
10. Anxiety diagnoses in smokers seeking cessation treatment: relations with tobacco dependence, withdrawal, outcome and response to treatment.
Piper ME; Cook JW; Schlam TR; Jorenby DE; Baker TB
Addiction; 2011 Feb; 106(2):418-27. PubMed ID: 20973856
[TBL] [Abstract][Full Text] [Related]
11. Anhedonia as a component of the tobacco withdrawal syndrome.
Cook JW; Piper ME; Leventhal AM; Schlam TR; Fiore MC; Baker TB
J Abnorm Psychol; 2015 Feb; 124(1):215-25. PubMed ID: 25384069
[TBL] [Abstract][Full Text] [Related]
12. A Randomized Clinical Trial of Nicotine Preloading for Smoking Cessation in People with Posttraumatic Stress Disorder.
Dedert EA; Dennis PA; Calhoun PS; Dennis MF; Beckham JC
J Dual Diagn; 2018; 14(3):148-157. PubMed ID: 29693495
[TBL] [Abstract][Full Text] [Related]
13. Transcranial Magnetic Stimulation Combined With Nicotine Replacement Therapy for Smoking Cessation: A Randomized Controlled Trial.
Trojak B; Meille V; Achab S; Lalanne L; Poquet H; Ponavoy E; Blaise E; Bonin B; Chauvet-Gelinier JC
Brain Stimul; 2015; 8(6):1168-74. PubMed ID: 26590478
[TBL] [Abstract][Full Text] [Related]
14. Effect of stress and bupropion on craving, withdrawal symptoms, and mood in smokers.
Kotlyar M; Drone D; Thuras P; Hatsukami DK; Brauer L; Adson DE; al'Absi M
Nicotine Tob Res; 2011 Jun; 13(6):492-7. PubMed ID: 21378081
[TBL] [Abstract][Full Text] [Related]
15. Smokers deprived of cigarettes for 72 h: effect of nicotine patches on craving and withdrawal.
Teneggi V; Tiffany ST; Squassante L; Milleri S; Ziviani L; Bye A
Psychopharmacology (Berl); 2002 Nov; 164(2):177-87. PubMed ID: 12404080
[TBL] [Abstract][Full Text] [Related]
16. The effect of bupropion on nicotine craving and withdrawal.
Shiffman S; Johnston JA; Khayrallah M; Elash CA; Gwaltney CJ; Paty JA; Gnys M; Evoniuk G; DeVeaugh-Geiss J
Psychopharmacology (Berl); 2000 Jan; 148(1):33-40. PubMed ID: 10663415
[TBL] [Abstract][Full Text] [Related]
17. Quit Intentions Moderate Subjective and Physiological Responses to Acute Nicotine Replacement Therapy Administration in Dependent Smokers.
Schlagintweit HE; Campbell NK; Barrett SP
Nicotine Tob Res; 2017 Aug; 19(8):922-929. PubMed ID: 27838660
[TBL] [Abstract][Full Text] [Related]
18. Smoking abstinence symptoms across 67 days compared with randomized controls-Moderation by nicotine replacement therapy, bupropion, and negative-affect traits.
Gilbert DG; Rabinovich NE; Gilbert-Matuskowitz EA; Klein KP; Pergadia ML
Exp Clin Psychopharmacol; 2019 Dec; 27(6):536-551. PubMed ID: 30920255
[TBL] [Abstract][Full Text] [Related]
19. Modeling naturalistic craving, withdrawal, and affect during early nicotine abstinence: A pilot ecological momentary assessment study.
Bujarski S; Roche DJ; Sheets ES; Krull JL; Guzman I; Ray LA
Exp Clin Psychopharmacol; 2015 Apr; 23(2):81-9. PubMed ID: 25844632
[TBL] [Abstract][Full Text] [Related]
20. The effect of nicotine dependence and withdrawal symptoms on use of nicotine replacement therapy: Secondary analysis of a randomized controlled trial in primary care.
Hollands GJ; Sutton S; Aveyard P
J Subst Abuse Treat; 2022 Jan; 132():108591. PubMed ID: 34391588
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
